Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy

Int J Antimicrob Agents. 2018 Jan;51(1):16-25. doi: 10.1016/j.ijantimicag.2017.11.002. Epub 2017 Nov 22.
No abstract available

Keywords: CA-MRSA; Infection control; MSSA; PVL; Panton–Valentine leukocidin; Staphylococcus aureus.

Publication types

  • Consensus Statement
  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Toxins* / metabolism
  • Chlorhexidine / pharmacology
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / microbiology
  • Community-Acquired Infections / prevention & control
  • Exotoxins* / metabolism
  • Humans
  • Leukocidins* / metabolism
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Mupirocin / pharmacology
  • Pets
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Bacterial / microbiology
  • Prevalence
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / epidemiology
  • Staphylococcal Infections* / etiology
  • Staphylococcal Infections* / prevention & control
  • Staphylococcal Skin Infections / drug therapy
  • Staphylococcal Skin Infections / microbiology
  • Staphylococcus aureus* / drug effects
  • Staphylococcus aureus* / metabolism
  • Staphylococcus aureus* / pathogenicity
  • Zoonoses / microbiology

Substances

  • Anti-Bacterial Agents
  • Bacterial Toxins
  • Chlorhexidine
  • Exotoxins
  • Leukocidins
  • Mupirocin
  • Panton-Valentine leukocidin